Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Journal of the International Neuropsychological Society : JINS|August 24, 2010
Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findingsMariana Cherner, Chad Bousman, Ian Everall, et al.
Schizophrenia Research|December 25, 2016
Functional brain networks in treatment-resistant schizophreniaEleni P Ganella, Cali F Bartholomeusz, Caio Seguin, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 25, 2022
Delineating gene-environment effects using virtual twins of patients treated with clozapineSam Mostafa, Thomas M Polasek, Chad Bousman, et al.
Human Psychopharmacology|September 10, 2013
Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depressionChee Ng, Jerome Sarris, Ajeet Singh, et al.
Journal of Affective Disorders|May 7, 2026
Pharmacogenomic testing for major depressive disorder in British Columbia, Canada: Recommendations from a public deliberationLouisa Edwards, Colene Bentley, Kieran C O'Doherty, et al.
BMC Psychiatry|July 31, 2016
Early origins of mental disorder - risk factors in the perinatal and infant periodLouise Newman, Fiona Judd, Craig A Olsson, et al.
Addictive Behaviors|July 14, 2019
Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunctionMariana Cherner, Caitlin W-M Watson, Rowan Saloner, et al.
Journal of Personalized Medicine|February 26, 2026
Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents (PGx-GAP): Study Protocol for a Randomized Controlled TrialMeagan Shields, Laina McAusland, Madison Heintz, et al.
International Clinical Psychopharmacology|January 9, 2016
Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatmentYun-Ai Su, Ji-Tao Li, Wen-Ji Dai, et al.
Psychiatry Research. Neuroimaging|September 3, 2018
The effects of a muscarinic receptor 1 gene variant on cortical thickness and surface area in schizophreniaSean P Carruthers, Caroline T Gurvich, Vanessa L Cropley, et al.
Pageof 7